Search research articles
Contact Us
Filters
Showing results (51-60 of 77) with videos related to
Page
of 8
Sort By:
Acta Neuropathologica
|
November 8, 2011
Pathology of immune reconstitution inflammatory syndrome in multiple sclerosis with natalizumab-associated progressive multifocal leukoencephalopathy
Imke Metz, Ernst-Wilhelm Radue, Agustin Oterino, et al.
Acta Neuropathologica Communications
|
June 18, 2026
Higher disease reactivation risk in women after fingolimod withdrawal
Marine Massy, Stefanie Marti, Adriane Kutllovci, et al.
Acta Neuropathologica
|
January 18, 2020
Antibody signatures in patients with histopathologically defined multiple sclerosis patterns
Lidia Stork, David Ellenberger, Klemens Ruprecht, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
February 20, 2016
Serum peptide reactivities may distinguish neuromyelitis optica subgroups and multiple sclerosis
Imke Metz, Tim Beißbarth, David Ellenberger, et al.
Annals of Neurology
|
August 5, 2015
Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque
Josa M Frischer, Stephen D Weigand, Yong Guo, et al.
Frontiers in Neurology
|
September 25, 2020
Case Report: A Case of Severe Clinical Deterioration in a Patient With Multiple Sclerosis
Katharina Breitkopf, Aykut Aytulun, Moritz Förster, et al.
Annals of Clinical and Translational Neurology
|
February 9, 2023
Long-term clinical, imaging and cognitive outcomes association with MS immunopathology
Alicja Kalinowska-Lyszczarz, Jan-Mendelt Tillema, William Oliver Tobin, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
July 27, 2016
Autoantibodies to MOG in a distinct subgroup of adult multiple sclerosis
Melania Spadaro, Lisa Ann Gerdes, Markus Krumbholz, et al.
Neurology
|
September 10, 2021
Clinical Correlation of Multiple Sclerosis Immunopathologic Subtypes
W Oliver Tobin, Alicja Kalinowska-Lyszczarz, Stephen D Weigand, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
September 13, 2011
Immunological and clinical consequences of treating a patient with natalizumab
Nicholas Schwab, Karin G Höhn, Tilman Schneider-Hohendorf, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 77) with videos related to
Sort By:
Page
of 8
Acta Neuropathologica
|
November 8, 2011
Pathology of immune reconstitution inflammatory syndrome in multiple sclerosis with natalizumab-associated progressive multifocal leukoencephalopathy
Imke Metz, Ernst-Wilhelm Radue, Agustin Oterino, et al.
Acta Neuropathologica Communications
|
June 18, 2026
Higher disease reactivation risk in women after fingolimod withdrawal
Marine Massy, Stefanie Marti, Adriane Kutllovci, et al.
Acta Neuropathologica
|
January 18, 2020
Antibody signatures in patients with histopathologically defined multiple sclerosis patterns
Lidia Stork, David Ellenberger, Klemens Ruprecht, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
February 20, 2016
Serum peptide reactivities may distinguish neuromyelitis optica subgroups and multiple sclerosis
Imke Metz, Tim Beißbarth, David Ellenberger, et al.
Annals of Neurology
|
August 5, 2015
Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque
Josa M Frischer, Stephen D Weigand, Yong Guo, et al.
Frontiers in Neurology
|
September 25, 2020
Case Report: A Case of Severe Clinical Deterioration in a Patient With Multiple Sclerosis
Katharina Breitkopf, Aykut Aytulun, Moritz Förster, et al.
Annals of Clinical and Translational Neurology
|
February 9, 2023
Long-term clinical, imaging and cognitive outcomes association with MS immunopathology
Alicja Kalinowska-Lyszczarz, Jan-Mendelt Tillema, William Oliver Tobin, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
July 27, 2016
Autoantibodies to MOG in a distinct subgroup of adult multiple sclerosis
Melania Spadaro, Lisa Ann Gerdes, Markus Krumbholz, et al.
Neurology
|
September 10, 2021
Clinical Correlation of Multiple Sclerosis Immunopathologic Subtypes
W Oliver Tobin, Alicja Kalinowska-Lyszczarz, Stephen D Weigand, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
September 13, 2011
Immunological and clinical consequences of treating a patient with natalizumab
Nicholas Schwab, Karin G Höhn, Tilman Schneider-Hohendorf, et al.
Page
of 8